Axogen Inc

LT3

Company Profile

  • Business description

    Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

  • Contact

    13631 Progress Boulevard
    Suite 400
    AlachuaFL32615
    USA

    T: +1 386 462-6800

    E: [email protected]

    https://www.axogeninc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    452

Stocks News & Analysis

stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,124.3027.40-0.30%
CAC 408,347.200.000.00%
DAX 4025,420.6615.320.06%
Dow JONES (US)49,191.99398.21-0.80%
FTSE 10010,137.353.35-0.03%
HKSE27,037.79189.320.71%
NASDAQ23,709.8724.03-0.10%
Nikkei 22554,413.92864.761.61%
NZX 50 Index13,718.0261.970.45%
S&P 5006,963.7413.53-0.19%
S&P/ASX 2008,793.9027.90-0.32%
SSE Composite Index4,179.4040.650.98%

Market Movers